Syncom Formulations (India) Limited (SYNCOMF) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE312C01025
Key metrics
- Market Cap
- ₹2,008 Cr
- P/E Ratio
- 23.73
- EPS
- 0.9
- Book Value
- 4.41
- P/B Ratio
- 4.86
- ROE
- 18.42%
- ROCE
- 17.02%
- Debt / Equity
- 0
- Net Margin
- 15.63%
- Revenue Growth
- 5.2%
- Profit Growth
- 54.62%
- Dividend Yield
- 0.47%
- 52W High
- ₹22.59
- 52W Low
- ₹10.21
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
- Headquarters
- Indore, India
- Promoter Holding
- 50.57%
The full Syncom Formulations (India) Limited analysis
Create a free account to open the complete SYNCOMF deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.